Is the plasma kallikrein-kinin system antithrombotic?

Blood

Volumn 108, Issue 1, 2006, Pages 1-2

  Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 12; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH MOLECULAR WEIGHT KININOGEN; MESSENGER RNA; NITRIC OXIDE; PREKALLIKREIN; PROSTACYCLIN;

BLEEDING TIME; DRUG ACTIVITY; ENZYME ACTIVITY; HUMAN; KALLIKREIN KININ SYSTEM; NOTE; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEPTOR BINDING; THROMBOSIS;

EID: 33745588287     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-04-016253     Document Type: Note

References (7)

1. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem. 1986;261:3486-3489.
2. Lin Y, Harris RB, Yan WY, McCrae KR, Colman RW. Inhibition of prourokinase-activated fibrinolysis on endothelial cell surfaces by high molecular weight kininogen peptides. Blood. 1997;90:690-697.
3. Puri RN, Colman RW. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues. Arch Biochem Biophys. 1991;286:419-427.
4. Colman RW, White JV, Scovell S, Stadnicki A, Sartor RB. Kininogens are antithrombotic proteins in vivo. Arterioscler Thromb Vasc Biol. 1999;19:2245-2250.
5. Kunapuli SP, Bradford HN, Jameson BA, et al. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen. J Biol Chem. 1996;271:11228-11235.
6. Hasan AA, Amenta S, Schmaier AH. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitor of alpha-thrombin-induced platelet activation. Circulation. 1996;94:517-528.
7. Tan Y, Hutchison FN, Jaffa AA. Mechanisms of angiotensin II-induced expression of B2 kinin receptors. Am J Physiol Heart Circ Physiol. 2004;286:H926-H932.